Europe - Netherlands
2

Industry focus: healthcare and life sciences

logo

NautaDutilh

More informationMore information

The practice at NautaDutilh has a solid track record in acting for pharma clients in a broad range of work, including transactional matters, patent proceedings and class action claims relating to medical devices. The 'exceptionally insightful' Ruud Smits is active in transactional work, and advises medical device, pharma, and biotech start-ups and investors on financing matters. Smits co-heads the department with Jeroen Boelens, a key contact for licensing and M&A issues, as well as multi-jurisdictional patent disputes. Paul van der Bijl is a name to note.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Ruud Smits kept a clear view on the important issues from a client perspective, and was very business minded.’

  • ‘Paul van der Bijl is exceptionally insightful, efficient and pragmatic. He’s focused on solutions and de-complexifying.’

  • ‘The practice has in-depth knowledge.’

  • ‘The Nauta team offers a wealth of legal expertise and experience. The team not only covers all Dutch law aspects, but also has extensive international experience in several selected areas, including capital markets and M&A. The team also has the skills and experience to offer its support in a broad perspective, taking a holistic view whenever necessary. The team is hands-on, responds quickly and provides very clear recommendations, without being dogmatic. ’

  • ‘Pragmatic, collaborative, resourceful and reliable. ’

  • ‘Ruud Smits is super pragmatic and understands thoroughly the company's perspective. I can always trust his team to be professional, supportive and reliable.’

Key clients

  • Forbion
  • NewAmsterdam Pharma
  • Pharvaris
  • GSK
  • Adcytherix
  • Avania
  • EQT Life Sciences
  • The Protein Brewery
  • Lumicks
  • Mimetas
  • Onera Health
  • Galenicum
  • Pharming Group

Work highlights

  • Advised a consortium of investors, led by Forbion and EQT Life Sciences, on the EUR 129m Series A investment round of VectorY Therapeutics B.V.
  • Acted as lead counsel to Pharming on its issuance of EUR 100 million senior unsecured convertible bonds due 2029.
  • Represented Galenicum Health in patent litigation against Insud Pharma.

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Ruud Smits, Jeroen Boelens

Other key lawyers

Paul van der Bijl, Joppe Schoute, Lauren Delleman